Dupilumab/mepolizumab/omalizumabHypereosinophilia and treatment failure: case report

被引:0
|
作者
机构
关键词
D O I
10.1007/s40278-025-77531-5
中图分类号
学科分类号
摘要
引用
收藏
页码:143 / 143
相关论文
共 50 条
  • [3] Rapid improvement of kimura disease with dupilumab in a patient with suboptimal response to mepolizumab: a case report
    Tao, Meiying
    Gao, Tingting
    Zhi, Lili
    Cao, Naiqing
    Liu, Haotian
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2025, 36 (01)
  • [5] Treatment of idiopathic anaphylaxis with dupilumab: a case report
    Pepper, Elizabeth
    Pittman, Luke
    ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2023, 19 (01):
  • [6] Treatment of idiopathic anaphylaxis with dupilumab: a case report
    Elizabeth Pepper
    Luke Pittman
    Allergy, Asthma & Clinical Immunology, 19
  • [7] Case report: Dupilumab for the treatment of bullous pemphigoid
    Wang, Mengxin
    Wang, Juan
    Shi, Bingjun
    DERMATOLOGIC THERAPY, 2022, 35 (07)
  • [8] Successful management of recurrent allergic bronchopulmonary aspergillosis after changing from mepolizumab to dupilumab: A case report
    Kai, Yoshiro
    Yoshikawa, Masanori
    Matsuda, Masayuki
    Suzuki, Kentaro
    Takano, Masato
    Tanimura, Kazuya
    Fujioka, Nobuhiro
    Fujita, Yukio
    Muro, Shigeo
    RESPIRATORY MEDICINE CASE REPORTS, 2022, 39
  • [10] Treatment of renal pruritus with dupilumab monotherapy: A case report
    Glockler-Lauf, S. Dresden
    Kirchhof, Mark G.
    SAGE OPEN MEDICAL CASE REPORTS, 2024, 12